These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17085852)

  • 21. Prodrugs in cardiovascular therapy.
    Sandros MG; Sarraf CB; Tabrizian M
    Molecules; 2008 May; 13(5):1156-78. PubMed ID: 18560335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral delivery of peptide drugs: barriers and developments.
    Hamman JH; Enslin GM; Kotzé AF
    BioDrugs; 2005; 19(3):165-77. PubMed ID: 15984901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo evaluation of microparticulate drug delivery systems composed of macromolecular prodrugs.
    Onishi H; Machida Y
    Molecules; 2008 Aug; 13(9):2136-55. PubMed ID: 18830146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dendrimer Prodrugs.
    da Silva Santos S; Igne Ferreira E; Giarolla J
    Molecules; 2016 May; 21(6):. PubMed ID: 27258239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prodrug design to improve pharmacokinetic and drug delivery properties: challenges to the discovery scientists.
    Jana S; Mandlekar S; Marathe P
    Curr Med Chem; 2010; 17(32):3874-908. PubMed ID: 20858214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do prodrugs deliver?
    Smith DA
    Curr Opin Drug Discov Devel; 2007 Sep; 10(5):550-9. PubMed ID: 17786853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted prodrugs in oral drug delivery: the modern molecular biopharmaceutical approach.
    Dahan A; Khamis M; Agbaria R; Karaman R
    Expert Opin Drug Deliv; 2012 Aug; 9(8):1001-13. PubMed ID: 22703376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prodrugs--from serendipity to rational design.
    Huttunen KM; Raunio H; Rautio J
    Pharmacol Rev; 2011 Sep; 63(3):750-71. PubMed ID: 21737530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipidic prodrug approach for improved oral drug delivery and therapy.
    Markovic M; Ben-Shabat S; Keinan S; Aponick A; Zimmermann EM; Dahan A
    Med Res Rev; 2019 Mar; 39(2):579-607. PubMed ID: 30320896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The 41st IUPAC World Chemistry Congress. 5-11 August 2007, Turin, Italy.
    Schettino V
    IDrugs; 2007 Oct; 10(10):706-8. PubMed ID: 17899488
    [No Abstract]   [Full Text] [Related]  

  • 31. Activation and Delivery of Tetrazine-Responsive Bioorthogonal Prodrugs.
    Wang Y; Zhang C; Wu H; Feng P
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33266075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scope and limitations of the co-drug approach to topical drug delivery.
    Lau WM; White AW; Gallagher SJ; Donaldson M; McNaughton G; Heard CM
    Curr Pharm Des; 2008; 14(8):794-802. PubMed ID: 18393881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanoparticles as delivery carriers for anticancer prodrugs.
    Fang JY; Al-Suwayeh SA
    Expert Opin Drug Deliv; 2012 Jun; 9(6):657-69. PubMed ID: 22507134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent Advances on Cellulose-Based Nano-Drug Delivery Systems: Design of Prodrugs and Nanoparticles.
    Dai L; Si C
    Curr Med Chem; 2019; 26(14):2410-2429. PubMed ID: 28699504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug targeting using conjugates: the importance of pharmaceutical chemistry.
    Byrn SR; Stowell JG
    J Drug Target; 1995; 3(4):239-41. PubMed ID: 8820996
    [No Abstract]   [Full Text] [Related]  

  • 36. Cytochrome P450-activated prodrugs: targeted drug delivery.
    Huttunen KM; Mähönen N; Raunio H; Rautio J
    Curr Med Chem; 2008; 15(23):2346-65. PubMed ID: 18855665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prodrugs as empowering tools in drug discovery and development: recent strategic applications of drug delivery solutions to mitigate challenges associated with lead compounds and drug candidates.
    Subbaiah MAM; Rautio J; Meanwell NA
    Chem Soc Rev; 2024 Feb; 53(4):2099-2210. PubMed ID: 38226865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Prodrug Approach: A Successful Tool for Improving Drug Solubility.
    Jornada DH; dos Santos Fernandes GF; Chiba DE; de Melo TR; dos Santos JL; Chung MC
    Molecules; 2015 Dec; 21(1):42. PubMed ID: 26729077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diverse approaches for the enhancement of oral drug bioavailability.
    Fasinu P; Pillay V; Ndesendo VM; du Toit LC; Choonara YE
    Biopharm Drug Dispos; 2011 May; 32(4):185-209. PubMed ID: 21480294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prodrugs of Antiinfective Agents: A Review.
    Piplani M; Rana AC; Sharma PC
    J Pharm Pharm Sci; 2016 Feb; 19(1):82-113. PubMed ID: 27096695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.